A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)

Clinical trial NCT01314872 · COMPLETED

Trial details

NCT number: NCT01314872
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urinary Bladder, Overactive

Start date: 2011-03-31
Primary completion: 2012-10-22
Enrollment: 1395

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.